Antirheumatic drugs and the risk of nonalcoholic fatty liver disease in patients with rheumatoid arthritis: A nationwide, population ‐based cohort study
ConclusionThis study reveals that NSAID use and prednisolone equivalent dose>5 mg/day were associated with an increased risk of NAFLD in patients with RA, while the use of HCQ and prednisolone equivalent dose ≤5 mg/day decreased the risk of NAFLD.
Source: International Journal of Rheumatic Diseases - Category: Rheumatology Authors: Chia ‐Chu Meng,
Der‐Yuan Chen,
Yi‐Hsing Chen,
Wen‐Nan Huang,
Hsin‐Hua Chen Tags: ORIGINAL ARTICLE Source Type: research
More News: Arthritis | Chia | Databases & Libraries | Eating Disorders & Weight Management | Fatty Liver Disease (FLD) | Health Insurance | Insurance | Liver | Liver Disease | Men | Non-alcoholic Fatty Liver Diseases (NAFLD) | Obesity | Prednisolone | Rheumatoid Arthritis | Rheumatology | Study | Urology & Nephrology